Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Horizon Therapeutics
Pharma
Amgen reaps Horizon buyout rewards in Q3, preps biosim launches
The company's overall sales grew 23% year over year and 8% excluding contributions from its Horizon Therapeutics buyout to $8.5 billion.
Zoey Becker
Oct 31, 2024 7:50am
Amgen's Uplizna posts strong results in myasthenia gravis trial
Sep 25, 2024 11:37am
Roche regains reputation crown among rare disease patient groups
Aug 20, 2024 11:25am
Improved access helps Amgen's Tepezza to a sales increase
Aug 7, 2024 8:35am
Amgen's Uplizna proves its worth in another rare disease
Jun 5, 2024 11:00am
Amid buzz for Amgen's obesity drug, company sees revenue boost
May 3, 2024 9:05am
